[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$f8MnTo7AsFZSWHZfbNoKeo5fQ44UYR8r9S78-nm1ZrAQ":8,"$fTjOtJekSUEzQv0yvVn8aPcBoPe32JZKhyWZwBP9c1AQ":55,"$fJdNTNaZMXIXrreRHzTTvXm7DEJLiQXGWLxDn8284Fvk":59},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},65327,867568,[],"https://ystcdn.venuertc.com/learnMaterial/ystApp//Qwz6GyCWTi4XHRajDQhvP0c86fSiOy65.png","李文旭","温州老年病医院","肿瘤科","主治医师",317,0,"肺癌放化疗药品使用细节全指南","","https://ystcdn.venuertc.com/venue/AI/a36721d6-60a5-46ce-b6a6-020da9f74605.jpg","\u003Cdiv class=\"lungchemo-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"lungchemo-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">肺癌放化疗药品使用细节全指南\u003C/h2>\n  \u003Cdiv class=\"lungchemo-intro\">\n    在放化疗药物的世界里，有些名字你或许并不陌生，例如铂类化疗药、靶向抑制剂以及免疫治疗药。它们广泛用于实体肿瘤治疗方案中，每种药物的使用方法和注意事项都不一样。其实，每一个小细节都直接关系到疗效和安全。本文为你梳理出7大关键药品用药细节，助你科学合理、安全用药。\n  \u003C/div>\n\n  \u003C!-- 01 剂型差异与服用技巧 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">💊\u003C/span>01 剂型差异与服用技巧\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      不同放化疗药物的剂型差异较大，包括注射剂（如顺铂、紫杉醇）、口服片剂（如吉非替尼、厄洛替尼、奥希替尼）、胶囊和缓释制剂。每种剂型对服用方式有特殊要求：\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>注射剂通常需由专业人员静脉输入，绝不可自行注射，需全程监护。\u003C/li>\n        \u003Cli>口服片剂如吉非替尼建议每日同一时间整片吞服，不可掰开或嚼碎；厄洛替尼应空腹或餐前1小时、餐后2小时服用。\u003C/li>\n        \u003Cli>缓释片、肠溶片禁止掰碎或碾成粉，否则药效会异常释放，副作用增加。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">每种药剂型的正确服用方法请务必仔细阅读说明书或咨询医师/药师，别凭主观想象服用。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 02 给药方案与最佳时间点 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">⏰\u003C/span>02 给药方案与最佳时间点\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      多数放化疗药物讲究严格的给药周期和具体时点。\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>顺铂、紫杉醇等静脉化疗药，通常以周期方式给药（如每3周1次，或根据医生处方调整），须严格遵从时间安排。\u003C/li>\n        \u003Cli>一些口服靶向药物如奥希替尼，每日一次，不建议间断或自行更改时间。\u003C/li>\n        \u003Cli>联合用药方案应保持相隔时间一致，随意提前或推迟都会影响疗效和毒副反应。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">请设定手机/闹钟提醒避免漏服，任何方案调整都需要医师确认后执行。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 03 作用机制要点简析 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">🔬\u003C/span>03 作用机制要点简析\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      放化疗药物主要分为三大类：\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>化疗药物（如顺铂、紫杉醇）\u003C/strong>：通过抑制细胞分裂，干扰DNA复制，导致异常细胞无法继续增殖。\u003C/li>\n        \u003Cli>\u003Cstrong>靶向药物（吉非替尼、奥希替尼、克唑替尼等）\u003C/strong>：有的抑制特定蛋白通路（如EGFR、ALK），有的阻断肿瘤营养供给（如贝伐珠单抗），药效更精准。\u003C/li>\n        \u003Cli>\u003Cstrong>免疫治疗药（如帕博利珠单抗等PD-1/PD-L1抑制剂）\u003C/strong>：解除肿瘤对免疫系统的抑制，帮助身体自身识别并清除异常细胞。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">每种药物介入方式和副作用表现均有差异，千万不要自行更换药物类别。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 04 用药周期与剂量控制 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">📋\u003C/span>04 用药周期与剂量控制\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      放化疗药品的剂量及周期设定非常严格。随意增减剂量、改变周期都可能降低疗效或增加不良反应。\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>听从医师安排，按方案完成每一疗程，不要提前终止。\u003C/li>\n        \u003Cli>如出现无法按时服用、呕吐、腹泻等情况，须及时告知医师以判断是否需要剂量调整。\u003C/li>\n        \u003Cli>不能基于自觉感觉“身体状况好转”就擅自减少服药频率。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">剂量和周期调整必须在医生监督下进行，绝不能随意操作。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 05 药物相互作用与食物影响 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">🥛\u003C/span>05 药物相互作用与食物影响\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      放化疗药物与其他药品、保健品、食品存在多种相互作用，需格外重视。\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>不可同时服用/须间隔使用药物\u003C/strong>：如厄洛替尼、奥希替尼等与质子泵抑制剂（奥美拉唑等）同服，会降低靶向药吸收效果，需错开服用。\u003Cbr>\n        \u003Cstrong>正确做法：\u003C/strong>靶向药建议空腹服，酸抑制药应至少间隔2小时以上。\u003C/li>\n        \u003Cli>\u003Cstrong>与食物的相互作用\u003C/strong>：说明书提示厄洛替尼遇高脂饮食吸收量增加，不规范饮食会导致药量控制失误。\u003C/li>\n        \u003Cli>\u003Cstrong>葡萄柚、圣约翰草\u003C/strong>等会影响多种口服抗肿瘤药物的代谢，宜全程避免。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">服药期间遇到需要联合其他药物时，请提前告知医生/药师。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 常见不良反应与应对措施 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">⚠️\u003C/span>06 常见不良反应与应对措施\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      放化疗药物相关不良反应较多，表现形式和处理方法略有差异。\u003Cbr>\n      \u003Cul>\n        \u003Cli>\u003Cstrong>化疗药物（顺铂、紫杉醇等）：\u003C/strong> 常见有恶心、呕吐、脱发、骨髓抑制（如白细胞减少）；同时可能出现肝肾损伤、神经毒性等。\u003C/li>\n        \u003Cli>\u003Cstrong>靶向药物：\u003C/strong> 皮疹、腹泻、口腔炎、指甲变形等较多，根据说明书不良反应发生率为“30%-60%”不等。\u003C/li>\n        \u003Cli>\u003Cstrong>免疫治疗药：\u003C/strong> 可有疲劳、皮疹、关节痛、胃肠道反应及免疫相关炎症反应。个别病例出现严重的不良反应，例如肺部炎症等。\u003C/li>\n      \u003C/ul>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Col>\n        \u003Cli>一旦出现持续性发热、异常出血、严重皮疹、呼吸困难等情况，应立即前往医院急诊。\u003C/li>\n        \u003Cli>轻微副作用可通过请求医师调整药物剂量或用相关对症支持药物缓解。\u003C/li>\n        \u003Cli>如合并其他任何用药，请主动报告，避免药物叠加不良反应。\u003C/li>\n      \u003C/ol>\n      \u003Cspan class=\"lungchemo-highlight\">任何异常反应都不可自行停药，务必向专业人员及时反馈。\u003C/span>\n      \u003Cdiv class=\"lungchemo-case\">\n        \u003Cstrong>临床案例：\u003C/strong>一位老年男性连续服用吉非替尼期间出现口腔炎，经调整饮食并外用局部护理，症状明显减轻，药物得以继续按方案使用。\n      \u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 07 特殊人群与用药调整 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">👨‍🦳\u003C/span>07 特殊人群与用药调整\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>老年人：\u003C/strong>代谢功能减弱，化疗剂量常需减低，对肝肾损伤和骨髓抑制监控更严；不建议随意加量。\u003C/li>\n        \u003Cli>\u003Cstrong>肝肾功能不全者：\u003C/strong>顺铂、吉西他滨等药物可加重肾脏损伤，应用中需动态评估，必要时减量或调整用药方案。\u003C/li>\n        \u003Cli>\u003Cstrong>孕妇/哺乳期：\u003C/strong>绝大多数放化疗药物对胎儿/哺乳期婴儿有高危风险，不建议在未评估风险的前提下用药。务必提前报告怀孕或哺乳计划。\u003C/li>\n        \u003Cli>\u003Cstrong>儿童/青少年：\u003C/strong>用药方案需由专科医师个体化制定，严禁自行参考成人方案。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">如遇上述情况，必须主动告知医师，以便实时动态调整治疗方案。\u003C/span>\n      \u003Cdiv class=\"lungchemo-case\">\u003Cstrong>实际病例：\u003C/strong>一位60岁男性在化疗过程中，因肾功能轻度异常，顺铂用量经医师调整后顺利完成治疗且未出现明显副作用。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 08 储存与药物管理规范 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">📦\u003C/span>08 储存与药物管理规范\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      放化疗药品存储规范性直接影响药效。\u003Cbr>\n      \u003Cstrong>正确做法：\u003C/strong>\n      \u003Cul>\n        \u003Cli>注射药品保存于2-8°C冰箱冷藏室，避免冷冻或暴露于高温、强光下。\u003C/li>\n        \u003Cli>口服片剂储存于阴凉干燥处，远离儿童或宠物活动区域。\u003C/li>\n        \u003Cli>药瓶开封后应按说明书要求，用完或到期及时销毁，避免自行保存备用。\u003C/li>\n        \u003Cli>过期药品切勿自行使用或随意处理，建议送至正规医疗垃圾处理点。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">正确的储存避免药效变质，也减少误服、伤害风险。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 漏服与过量处理 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">🔄\u003C/span>09 漏服与过量服用的应对\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      药物服用时间的连续性直接影响治疗效果。\n      \u003Cul>\n        \u003Cli>\u003Cstrong>漏服：\u003C/strong>一旦漏服口服药，若发现时间距离下次服药较为接近，直接跳过漏服部分，不要一次补两倍剂量。\u003C/li>\n        \u003Cli>\u003Cstrong>过量：\u003C/strong>大剂量误服后，常出现明显副作用，如腹泻、出血等。请立即带上药盒前往医院急诊处理。\u003C/li>\n        \u003Cli>静脉化疗药物用药过程中，若突然出现异常症状，应立即呼叫医务人员处理，切忌惊慌自行停药。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">严格按照医嘱执行，切勿因情绪波动私自调整药物数量或频次。\u003C/span>\n      \u003Cdiv class=\"lungchemo-case\">\u003Cstrong>服药经验：\u003C/strong>有患者在服用厄洛替尼期间因忘记服药，及时与医生沟通后未补服，未出现明显异常，顺利继续后续方案。\u003C/div>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 10 合理用药小结与核心注意 -->\n  \u003Csection class=\"lungchemo-section\">\n    \u003Cdiv class=\"lungchemo-subtitle-bg\">\u003Ch2 class=\"lungchemo-section-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">\u003Cspan class=\"lungchemo-emoji\">✅\u003C/span>10 合理用药小结与核心注意\u003C/h2>\u003C/div>\n    \u003Cdiv class=\"lungchemo-content\">\n      放化疗药物覆盖范围广，临床应用复杂。安全合理用药的核心在于“严格按方案”“全程监控”“及时报告任何异常”。\u003Cbr>\n      \u003Cstrong>最终建议：\u003C/strong>\n      \u003Cul>\n        \u003Cli>始终遵循医师与药师的权威指导，出入院时再三核对药物种类与剂型。\u003C/li>\n        \u003Cli>出现任一不良反应或用药问题，第一时间联系专业人员。\u003C/li>\n        \u003Cli>养成检查药品有效期、规范储存的好习惯。\u003C/li>\n        \u003Cli>不要擅自停药、换药、加量或减量。\u003C/li>\n      \u003C/ul>\n      \u003Cspan class=\"lungchemo-highlight\">安全用药，每一步都至关重要。\u003C/span>\n    \u003C/div>\n  \u003C/section>\n\n  \u003Csection class=\"lungchemo-references\">\n    \u003Ch3 class=\"lungchemo-reference-title\" style=\"color: rgb(44, 62, 80); margin: 1.2em 0px 0.6em; font-weight: 700; border-bottom: 1px solid rgb(238, 238, 238);\">文献引用\u003C/h3>\n    \u003Col class=\"lungchemo-ref-list\">\n      \u003Cli>\n        Mok, T. S., Wu, Y. L., & Thongprasert, S. (2009). Gefitinib or carboplatin–paclitaxel in pulmonary adenocarcinoma. \u003Ci>New England Journal of Medicine, 361\u003C/i>(10), 947-957.\n      \u003C/li>\n      \u003Cli>\n        Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., et al. (2006). Paclitaxel–carboplatin alone or with bevacizumab for non–small-cell lung cancer. \u003Ci>New England Journal of Medicine, 355\u003C/i>(24), 2542-2550.\n      \u003C/li>\n      \u003Cli>\n        Gandhi, L., Rodríguez-Abreu, D., Gadgeel, S., Esteban, E., Felip, E., et al. (2018). Pembrolizumab plus chemotherapy in metastatic non–small-cell lung cancer. \u003Ci>New England Journal of Medicine, 378\u003C/i>(22), 2078-2092.\n      \u003C/li>\n      \u003Cli>\n        National Comprehensive Cancer Network (NCCN). (2023). \u003Ci>NCCN Clinical Practice Guidelines in Oncology: Non-Small Cell Lung Cancer\u003C/i>.\n      \u003C/li>\n      \u003Cli>\n        Socinski, M. A., Obasaju, C., Gandara, D., Hirsch, F. R., Bonomi, P., et al. (2016). Current and future therapies for stage IV non–small cell lung cancer: a review. \u003Ci>Lung Cancer, 89\u003C/i>, 16-27.\n      \u003C/li>\n    \u003C/ol>\n  \u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.lungchemo-wrapper {\n  max-width: 820px;\n  margin: 36px auto;\n  padding: 28px 24px 32px 24px;\n  background: #fafdff;\n  font-family: 'PingFang SC', 'Microsoft Yahei', Arial, sans-serif;\n  color: #212121;\n  border-radius: 16px;\n  box-shadow: 0 8px 30px rgba(80,124,137,0.07);\n  line-height: 1.85;\n  min-height: 300px;\n}\n.lungchemo-title {\n  font-size: 2.4em;\n  letter-spacing: 2px;\n  font-weight: 800;\n  color: #1a496d;\n  text-align: center;\n  margin-bottom: 32px;\n  margin-top: 0;\n  line-height: 1.2;\n}\n.lungchemo-intro {\n  background: linear-gradient(90deg,#f2fafe 15%, #eaf5fc 100%);\n  border-left: 5px solid #3897c4;\n  padding: 18px 22px;\n  border-radius: 10px;\n  font-size: 1.09em;\n  margin-bottom: 34px;\n}\n.lungchemo-section {\n  margin-bottom: 44px;\n  border-radius: 12px;\n  overflow: hidden;\n  box-shadow: 0 2px 12px rgba(60,120,160,0.06);\n  background: #fff;\n}\n.lungchemo-subtitle-bg {\n  background-image: linear-gradient(90deg,#e3eff5 0%, #e7ecf3 100%);\n  padding: 12px 18px 8px 18px;\n}\n.lungchemo-section-title {\n  font-size: 1.35em;\n  color: #236893;\n  font-weight: 700;\n  margin: 0;\n  letter-spacing: 1.5px;\n  display: inline-block;\n}\n.lungchemo-emoji {\n  font-size: 1.2em;\n  margin-right: 4px;\n}\n.lungchemo-content {\n  padding: 22px 24px 18px 24px;\n  font-size: 1.09em;\n  background: #fbfdfe;\n}\n.lungchemo-content ul, .lungchemo-content ol {\n  margin: 8px 0 8px 20px;\n}\n.lungchemo-content li {\n  margin-bottom: 7px;\n}\n.lungchemo-highlight {\n  display: block;\n  background: linear-gradient(90deg,#e1f6fa 40%,#f4fbfa 100%);\n  color: #245a73;\n  border-left: 4px solid #53b8db;\n  padding: 9px 12px;\n  font-weight: 500;\n  font-size: 1.04em;\n  margin: 14px 0 2px 0;\n  border-radius: 5px;\n}\n.lungchemo-case {\n  margin: 17px 0 5px 0;\n  background: #e9f1fa;\n  color: #283e5b;\n  padding: 9px 14px;\n  border-left: 3px solid #3b94e0;\n  border-radius: 4px;\n  font-size: 1.03em;\n}\n.lungchemo-references {\n  padding: 18px 14px;\n  margin-top: 40px;\n  border-radius: 10px;\n  background: linear-gradient(90deg,#f5f6fc 50%,#eafafc 100%);\n  font-size: 1.01em;\n}\n.lungchemo-reference-title {\n  color: #19496c;\n  font-weight: 700;\n  font-size: 1.12em;\n  margin-top: 0;\n  margin-bottom: 10px;\n  letter-spacing: 1px;\n}\n.lungchemo-ref-list {\n  margin-top: 0;\n  margin-bottom: 0;\n  padding-left: 16px;\n}\n.lungchemo-ref-list li {\n  margin-bottom: 6px;\n  line-height: 1.65;\n}\n@media (max-width: 980px) {\n  .lungchemo-wrapper {\n    padding: 12px 5% 18px 5%;\n  }\n}\n@media (max-width: 600px) {\n  .lungchemo-title {\n    font-size: 1.45em;\n  }\n  .lungchemo-content, .lungchemo-intro, .lungchemo-references {\n    font-size: 0.97em;\n    padding-left: 8px;\n    padding-right: 8px;\n  }\n  .lungchemo-section {\n    border-radius: 7px;\n  }\n  .lungchemo-subtitle-bg {\n    padding: 8px 10px 5px 12px;\n  }\n}\n\u003C/style>\n\n","\u003Cdiv class=\"lungchemo-wrapper\">\n  \u003Ch2 id=\"material_title\" class=\"lungchemo-title\" style=\"color: rgb(",526,"2025-09-01 14:08:19","肺癌放化疗, 放化疗药物, 用药细节, 不良反应, 安全用药, 剂型差异, 给药方案, 靶向药物, 免疫治疗, 药物相互作用","本文全面梳理肺癌放化疗的重要药品使用细节，确保患者科学合理、安全用药。了解剂型、给药方案及常见不良反应，让每位患者在治疗过程中得到最大保障。","2025-09-05 06:06:25",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤,重大疾病",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":57,"result":58,"totalSize":21},10,[],{"code":9,"msg":10,"message":6,"data":60,"success":54},{"authors":61,"appraiseDimensionScoresVos":62},[],[]]